Cochrane Abstracts
Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide New
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Prognostic Value of Test(s) for O6‐methylguanine–DNA Methyltransferase (MGMT) Promoter Methylation for Predicting Overall Survival in People With Glioblastoma Treated With Temozolomide New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431926/all/Antibiotics_for_persistent_nasal_discharge__rhinosinusitis__in_children:_Cochrane_systematic_review. Accessed 31 May 2023.
Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/all/Antibiotics_for_persistent_nasal_discharge__rhinosinusitis__in_children:_Cochrane_systematic_review. Accessed May 31, 2023.
Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide New. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/all/Antibiotics_for_persistent_nasal_discharge__rhinosinusitis__in_children:_Cochrane_systematic_review
Prognostic Value of Test(s) for O6‐methylguanine–DNA Methyltransferase (MGMT) Promoter Methylation for Predicting Overall Survival in People With Glioblastoma Treated With Temozolomide New [Internet]. In: Cochrane Abstracts. [cited 2023 May 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/all/Antibiotics_for_persistent_nasal_discharge__rhinosinusitis__in_children:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Prognostic value of test(s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide New
ID - 431926
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431926/all/Antibiotics_for_persistent_nasal_discharge__rhinosinusitis__in_children:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
